- Medical - Devices
- Healthcare
Bio-Rad Laboratories, Inc.
BIO · US ·
NYSE
325.29
USD
-3.07
(0.94%)
-
-46.68
EPS
-
-6.97
P/E
-
9.08B
MARKET CAP
-
0.00%
DIV YIELD
EPS Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | CAGR | |
|---|---|---|---|---|---|---|
| High Estimate | -45.5 | 9.87 | 9.71 | 11.1 | 15 | 23.54% |
| Avg. Estimate | -46.2 | 9.82 | 9.6 | 11 | 14.8 | 23.42% |
| Low Estimate | -46.7 | 9.76 | 9.46 | 10.8 | 14.6 | 23.31% |
| No. Of Analysts | 2 | 4 | 3 | 1 | 0 |
Revenue Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | CAGR | |
|---|---|---|---|---|---|---|
| High Estimate | 2.59B | 2.61B | 2.76B | 2.82B | 2.99B | 3.69% |
| Avg. Estimate | 2.56B | 2.59B | 2.7B | 2.8B | 2.96B | 3.69% |
| Low Estimate | 2.53B | 2.56B | 2.64B | 2.76B | 2.93B | 3.69% |
| No. Of Analysts | 4 | 3 | 4 | 4 | 2 |
Net Income Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | CAGR | |
|---|---|---|---|---|---|---|
| High Estimate | -459M | 288M | 284M | 324M | 437M | 31.08% |
| Avg. Estimate | -1.33B | 287M | 274M | 313M | 432M | 23.50% |
| Low Estimate | -2.19B | 285M | 276M | 315M | 426M | 21.71% |
| No. Of Analysts | 4 | 3 | 4 | 4 | 2 |